These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11236746)

  • 1. Betablockers in the New Millennium. Hamburg meeting, April 1, 2000. Proceedings.
    Basic Res Cardiol; 2000; 95 Suppl 1():I1-103. PubMed ID: 11236746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cardiovascular diseases with beta-blockers: the place of metoprolol and its various drug formulations].
    Martsevich SIu
    Kardiologiia; 2003; 43(12):78-81. PubMed ID: 15035258
    [No Abstract]   [Full Text] [Related]  

  • 3. [beta-Adrenoblockers in cardiology: metoprolol succinate].
    Zateĭshchikov DA; Dankovtseva EN
    Kardiologiia; 2007; 47(8):87-92. PubMed ID: 18260921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and safety of metoprolol CR/XL: confidence based on proofs].
    Skibitskiĭ VV
    Kardiologiia; 2008; 48(9):62-5. PubMed ID: 18991824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenergic betablockers and heart failure].
    Lechat P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 7. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    Cazzola M; Matera MG
    Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factor modulation with new generation vasodilating beta-blockers. Official satellite to the thirteenth scientific meeting of the International Society of Hypertension. Montreal, Canada, June 24, 1990.Proceedings.
    Am Heart J; 1991 Mar; 121(3 Pt 2):989-1032. PubMed ID: 1671729
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulsatile multiparticulate drug delivery system for metoprolol succinate.
    Jagdale SC; Chede SM; Gulwady R; Kuchekar BS; Lokhande PD; Shah TP; Chabukswar AR
    Arch Pharm Res; 2011 Mar; 34(3):369-76. PubMed ID: 21547667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving ventricular rate control using metoprolol in β-blocker-naive patients vs patients on chronic β-blocker therapy.
    Kuang P; Mah ND; Barton CA; Miura AJ; Tanas LR; Ran R
    Am J Emerg Med; 2016 Mar; 34(3):606-8. PubMed ID: 26830391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials of various glaucoma drugs acting on the adrenergic system (author's transl)].
    Urner-Bloch U; Bucheli J; Eltz H; Gloor B; Aeschlimann J
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):555-7. PubMed ID: 6106729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta Blockade in Cardiovascular Disease: Current Perspectives on Patient Protection. Symposium proceedings. New Orleans, Louisiana, November 10, 1996.
    Am J Cardiol; 1997 Nov; 80(9B):1J-58J. PubMed ID: 9412242
    [No Abstract]   [Full Text] [Related]  

  • 15. Should physicians initiate beta-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial.
    Alonso-Coello P; Paniagua P; Mizera R; Devereaux PJ
    Pol Arch Med Wewn; 2008 Nov; 118(11):616-8. PubMed ID: 19140563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metoprolol in the treatment of essential hypertension].
    Minushkina LO; Sidorenko BA
    Kardiologiia; 2003; 43(11):102-5. PubMed ID: 14671567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COMET: metoprolol].
    Handa S
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():521-5. PubMed ID: 17511103
    [No Abstract]   [Full Text] [Related]  

  • 18. [The place of metoprolol in the treatment of ischemic heart disease].
    Tereshchenko SN; Kositsyna IV; Dzhaiani NA
    Kardiologiia; 2005; 45(4):98-101. PubMed ID: 15940205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carvedilol or metoprolol European trial.
    Meyer TE
    Curr Cardiol Rep; 2004 May; 6(3):198-9. PubMed ID: 15075055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.